Connection

Elizabeth Garrett-Mayer to Tumor Stem Cell Assay

This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Tumor Stem Cell Assay.
  1. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014 Aug; 16(8):644-55.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.